Utilization of mental health and substance abuse care for people living with HIV/AIDS, chronic mental illness, and substance abuse disorders

Journal of Acquired Immune Deficiency Syndromes : JAIDS
Marcia R WeaverCost Subcommittee of the HIV/AIDS Treatment Adherence, Health Outcomes, and Cost Study Group

Abstract

To examine the effects of race/ethnicity, insurance, and type of substance abuse (SA) diagnosis on utilization of mental health (MH) and SA services among triply diagnosed adults with HIV/AIDS and co-occurring mental illness (MI) and SA disorders. Baseline (2000 to 2002) data from the HIV/AIDS Treatment Adherence, Health Outcomes, and Cost Study. A multiyear cooperative agreement with 8 study sites in the United States. The Structured Clinical Interview for DSM-IV Axis I Disorders (SCID) was administered by trained interviewers to determine whether or not adults with HIV/AIDS had co-occurring MI and SA disorders. Subjects were interviewed in person about their personal characteristics and utilization of MH and SA services in the prior 3 months. Data on HIV viral load were abstracted from their medical records. Only 33% of study participants received concurrent treatment for MI and SA, despite meeting diagnostic criteria for both: 26% received only MH services, 15% received only SA services, and 26% received no services. In multinomial logistic analysis, concurrent utilization of MH and SA services was significantly lower among nonwhite and Hispanic participants as a group and among those who were not dependent on drugs and alco...Continue Reading

References

Jan 1, 1994·International Journal of Psychiatry in Medicine·C G LyketsosG J Treisman
Jul 1, 1996·Psychiatric Services : a Journal of the American Psychiatric Association·K Humphreys, R H Moos
Jul 1, 1999·JAMA : the Journal of the American Medical Association·M F ShapiroS A Bozzette
Aug 17, 1999·Medical Care·L RabeneckN P Wray
Feb 15, 2000·The American Journal of Psychiatry·C D SherbourneM F Shapiro
May 2, 2001·The Journal of Behavioral Health Services & Research·R Sturm, C D Sherbourne
Oct 6, 2001·Journal of Acquired Immune Deficiency Syndromes : JAIDS·S R SmithUNKNOWN ACSUS (Aids Costs and Services Utilization Survey)
Sep 19, 2002·Health Services Research·Kenneth B WellsM Audrey Burnam
Mar 4, 2003·The American Journal of Psychiatry·Benedetto VitielloMartin F Shapiro
Jul 3, 2003·Community Mental Health Journal·Matthew T TheriotMax J Cowsert
Nov 8, 2003·Journal of Health Economics·Jayanta BhattacharyaNeeraj Sood
Feb 1, 2005·Southern Medical Journal·Kathryn WhettenTomas Soto
Mar 2, 2005·AIDS Care·W D KlinkenbergUNKNOWN HIV/AIDS Treatment Adherence, Health Outcomes and Cost Study Group
Mar 2, 2005·AIDS Care·T A SotoUNKNOWN HIV/AIDS Treatment Adherence, Health Outcomes and Cost Study Group
Mar 2, 2005·AIDS Care·K K UldallUNKNOWN HIV/AIDS Treatment Adherence, Health Outcomes and Cost Study Group
Apr 28, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Brian Wells PenceBradley N Gaynes

❮ Previous
Next ❯

Citations

Feb 17, 2009·Journal of Clinical Psychology in Medical Settings·Rodger KesslerRandall Messier
Apr 23, 2011·Journal of Clinical Psychology in Medical Settings·Kyle Possemato
Aug 9, 2008·Current Infectious Disease Reports·Ank NijhawanJosiah D Rich
Dec 6, 2012·Journal of Psychoactive Drugs·Howard PadwaRichard A Rawson
Aug 10, 2011·Journal of American College Health : J of ACH·Henry ChungCaroline Kasnakian
Sep 18, 2010·AIDS Patient Care and STDs·Rae Jean Proeschold-BellEvelyn Byrd Quinlivan
Oct 12, 2012·AIDS Patient Care and STDs·Susan S ReifKathryn Whetten
Mar 16, 2013·American Journal of Public Health·Ruth Shim, George Rust
Feb 15, 2014·American Journal of Public Health·Erick G GuerreroLawrence A Palinkas
Jan 23, 2013·Community Mental Health Journal·Suzan J SongJoop de Jong
Nov 25, 2014·Cognitive and Behavioral Practice·Jessica F MagidsonStacey B Daughters
Jan 5, 2013·American Journal of Epidemiology·Steven S Coughlin
Sep 30, 2015·AIDS and Behavior·Rafael Ballester-ArnalM José Fuster
Dec 22, 2009·AIDS Care·Christopher J ConoverUNKNOWN HIV/AIDS Treatment Adherence, Health Outcomes and Cost Study
Aug 9, 2012·The Journal of the Association of Nurses in AIDS Care : JANAC·Megha RamaswamyJulia H Arnsten
Jun 26, 2012·Research in Social & Administrative Pharmacy : RSAP·Vishal BaliNasreen Khan
Feb 5, 2010·Journal of Substance Abuse Treatment·Sherry LipskyAlice Huber
Oct 30, 2014·Journal of Intellectual Disability Research : JIDR·V Pezzoni, C Kouimtsidis
Aug 12, 2014·AIDS Care·Angela M BengtsonBradley Gaynes
Jul 19, 2012·International Journal of STD & AIDS·A T OlagunjuO A Ogundipe
Apr 18, 2018·AIDS Research and Human Retroviruses·Cindy LauTony Antoniou
Feb 13, 2019·Current HIV/AIDS Reports·Anthony E HitchJennifer L Brown
Mar 26, 2019·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Rulin C HechterDerek D Satre
Feb 12, 2009·Addiction·Jean-Paul BernardHassan Zaré Khiabani
Dec 19, 2018·Health & Social Work·Lisa A HarkScott J Fudemberg
Nov 7, 2018·Journal of Innovation in Health Informatics·Tanisha Tate WoodsonDeborah J Cohen
Jul 30, 2019·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Matthew E LevyAmanda D Castel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.